Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford skyline

This new course will provide a thorough grounding and introduction to those planning on becoming a Chief Investigator or those recently appointed to this role. The day will consist of presentations on how to communicate effectively, facilitating the actions required from a CI, guidance on the methods that can be employed, issues that may occur and how to develop and report your trial.

The course is free of charge and will include lunch and refreshments and a comprehensive delegate pack including associated reading.  The presentations will be given by experienced Chief Investigators, Regulatory Experts and senior members of OCTRU and the Centre for Statistics in Medicine.

The course will be held in the Lecture Theatre at the Botnar Research Centre, Oxford.

PLEASE NOTE PLACES ARE LIMITED.  To reserve a place, please email octrutrialshub@ndorms.ox.ac.uk to receive further details. 

Similar stories

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.